Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help?
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
Choosing Common Pain Relievers: It's Complicated
91社区 Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Osher LLI at 91社区 Presents Douglas Brinkley
The Osher LLI at 91社区 in Jupiter will present a lecture by Douglas Brinkley, CNN presidential historian and author, on Tuesday, Feb. 25 at 7 p.m. in the Osher LLI complex at 91社区 Jupiter.
Publicly Funded Pregnancy Programs Improve Maternal Mortality Rates
Maternal mortality rates in the United States exceed those of other developed countries, with some considerable racial disparities.
Researchers Take Body Armor to the Next Level with High Energy Fibers
91社区's College of Engineering and Computer Science received $569,482 from Combating Terrorism Technical Support Office to develop advanced fibers to enhance the performance of military helmets and body armor.
91社区 to Host Events in Honor of Black/African American History Month
91社区 will celebrate Black/African American History Month with a series of events throughout the month of February at its Boca Raton, Jupiter and Broward campuses.
91社区 College of Business Honors Rita and Rick Case
91社区's College of Business recently honored Rita and Rick Case of the Rick Case Automotive Group at its 28th annual Business Leaders of the Year breakfast at the Boca Raton Resort & Club.
91社区 Receives Carnegie Foundation Community Engagement Classification
The Carnegie Foundation has announced that 91社区 is one of the 119 U.S. colleges and universities to receive the Carnegie Community Engagement Classification for 2020.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from 91社区's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.